Menu
GWAS Study

New susceptibility loci associated with kidney disease in type 1 diabetes.

Sandholm N, Salem RM, McKnight AJ et al.

23028342 PubMed ID
GWAS Study Type
10915 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SN
Sandholm N
SR
Salem RM
MA
McKnight AJ
BE
Brennan EP
FC
Forsblom C
IT
Isakova T
MG
McKay GJ
WW
Williams WW
SD
Sadlier DM
MV
Mäkinen VP
SE
Swan EJ
PC
Palmer C
BA
Boright AP
AE
Ahlqvist E
DH
Deshmukh HA
KB
Keller BJ
HH
Huang H
AA
Ahola AJ
FE
Fagerholm E
GD
Gordin D
HV
Harjutsalo V
HB
He B
HO
Heikkilä O
HK
Hietala K
KJ
Kytö J
LP
Lahermo P
LM
Lehto M
LR
Lithovius R
OA
Osterholm AM
PM
Parkkonen M
PJ
Pitkäniemi J
RM
Rosengård-Bärlund M
SM
Saraheimo M
SC
Sarti C
SJ
Söderlund J
SA
Soro-Paavonen A
SA
Syreeni A
TL
Thorn LM
TH
Tikkanen H
TN
Tolonen N
TK
Tryggvason K
TJ
Tuomilehto J
WJ
Wadén J
GG
Gill GV
PS
Prior S
GC
Guiducci C
MD
Mirel DB
TA
Taylor A
HS
Hosseini SM
PH
Parving HH
RP
Rossing P
TL
Tarnow L
LC
Ladenvall C
AF
Alhenc-Gelas F
LP
Lefebvre P
RV
Rigalleau V
RR
Roussel R
TD
Tregouet DA
MA
Maestroni A
MS
Maestroni S
FH
Falhammar H
GT
Gu T
MA
Möllsten A
CD
Cimponeriu D
IM
Ioana M
MM
Mota M
ME
Mota E
SC
Serafinceanu C
SM
Stavarachi M
HR
Hanson RL
NR
Nelson RG
KM
Kretzler M
CH
Colhoun HM
PN
Panduru NM
GH
Gu HF
BK
Brismar K
ZG
Zerbini G
HS
Hadjadj S
MM
Marre M
GL
Groop L
LM
Lajer M
BS
Bull SB
WD
Waggott D
PA
Paterson AD
SD
Savage DA
BS
Bain SC
MF
Martin F
HJ
Hirschhorn JN
GC
Godson C
FJ
Florez JC
GP
Groop PH
MA
Maxwell AP
Chapter II

Abstract

Summary of the research findings

Diabetic kidney disease, or diabetic nephropathy (DN), is a major complication of diabetes and the leading cause of end-stage renal disease (ESRD) that requires dialysis treatment or kidney transplantation. In addition to the decrease in the quality of life, DN accounts for a large proportion of the excess mortality associated with type 1 diabetes (T1D). Whereas the degree of glycemia plays a pivotal role in DN, a subset of individuals with poorly controlled T1D do not develop DN. Furthermore, strong familial aggregation supports genetic susceptibility to DN. However, the genes and the molecular mechanisms behind the disease remain poorly understood, and current therapeutic strategies rarely result in reversal of DN. In the GEnetics of Nephropathy: an International Effort (GENIE) consortium, we have undertaken a meta-analysis of genome-wide association studies (GWAS) of T1D DN comprising ~2.4 million single nucleotide polymorphisms (SNPs) imputed in 6,691 individuals. After additional genotyping of 41 top ranked SNPs representing 24 independent signals in 5,873 individuals, combined meta-analysis revealed association of two SNPs with ESRD: rs7583877 in the AFF3 gene (P = 1.2 × 10(-8)) and an intergenic SNP on chromosome 15q26 between the genes RGMA and MCTP2, rs12437854 (P = 2.0 × 10(-9)). Functional data suggest that AFF3 influences renal tubule fibrosis via the transforming growth factor-beta (TGF-β1) pathway. The strongest association with DN as a primary phenotype was seen for an intronic SNP in the ERBB4 gene (rs7588550, P = 2.1 × 10(-7)), a gene with type 2 diabetes DN differential expression and in the same intron as a variant with cis-eQTL expression of ERBB4. All these detected associations represent new signals in the pathogenesis of DN.

Up to 2,916 European ancestry Type 1 Diabetes cases with nephropathy, 3,315 European ancestry Type 1 Diabetes cases without nephropathy

Chapter III

Study Statistics

Key metrics and study information

10915
Total Participants
GWAS
Study Type
Yes
Replicated
Up to 1,493 European ancestry Type 1 Diabetes cases with nephropathy, 3,191 European ancestry Type 1 Diabetes cases without nephropathy
Replication Participants
European
Ancestry
Finland, U.S., U.K., Republic of Ireland, Sweden, Italy, Romania, Canada, Belgium, France, Denmark
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.